Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciSparc Ltd. ( (SPRC) ) has provided an announcement.
On July 3, 2025, SciSparc Ltd. implemented a one-for-twenty-one reverse share split of its ordinary shares. This adjustment led to revisions in the company’s audited consolidated financial statements for the year ending December 31, 2024. The reverse split and subsequent financial statement revisions are part of SciSparc’s efforts to address ongoing financial challenges, including recurring operational losses and liquidity concerns, which have raised doubts about its ability to continue as a going concern.
More about SciSparc Ltd.
SciSparc Ltd. operates in the pharmaceutical industry, focusing on developing therapies for central nervous system disorders. The company is based in Tel Aviv, Israel, and is engaged in creating innovative treatments for conditions such as Alzheimer’s disease and Tourette syndrome.
Average Trading Volume: 107,089
Technical Sentiment Signal: Hold
Current Market Cap: $4.03M
For detailed information about SPRC stock, go to TipRanks’ Stock Analysis page.